Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI Listing Regulations about the date of a Board meeting to consider financial results and dividend recommendation. It does not itself contain financial results or attach a report, nor announce management changes. It is a regulatory announcement to the stock exchanges, fitting the general regulatory filings category.
2026-05-26 English
General Updates
Share Issue/Capital Change Classification · 92% confidence The document is an official disclosure sent to BSE/NSE under Regulation 30 of SEBI LODR, announcing board approval and in-principle approval application for preferential allotment of convertible warrants and enclosing a valuation report and compliance certificate. This is a corporate action involving a new share issue (preferential allotment of warrants), which falls under Share Issue/Capital Change.
2026-05-12 English
Please refer to the attachment.
Capital/Financing Update Classification · 78% confidence The document is a disclosure under SEBI Listing Regulations informing stock exchanges about the preferential allotment of convertible warrants – a financing/capital-raising activity. It provides a valuation report and updated compliance certificate in connection with that transaction. This falls under updates on company fundraising or capital structure changes (Capital/Financing Update).
2026-05-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter from Themis Medicare Limited addressed to stock exchanges (BSE and NSE) regarding a newspaper publication notice about a special window for re-lodgement of transfer requests and dematerialisation of physical shares. It references a SEBI circular and includes details about the publication in newspapers and availability on the company's website. The content is an announcement of a notice publication rather than the notice or report itself. The document is about informing the exchanges and public about the publication of a notice, not the notice content or a financial report. It is not a financial report, earnings release, management discussion, or any other detailed report type. It is also not a certification or insider dealing report. The document is relatively short and serves as an announcement for information and records. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification to exchanges about a publication related to share transfer procedures.
2026-04-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure of shareholding under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. It details the promoter and promoter group shareholding status and mentions no encumbrance over shares during the financial year ended 31 March 2026. This type of disclosure is related to changes or confirmations in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a full financial report, audit, or management report, nor is it an announcement of a report publication. It is a regulatory disclosure about shareholding status and changes, fitting the MRQ category with high confidence.
2026-04-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2026. It is issued by the Registrar and Share Transfer Agent confirming dematerialisation of securities and related compliance. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a formal attestation related to securities and shareholder records. The document length is 3358 characters, which is relatively short and focused on certification. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a full report or announcement of financial results or corporate actions.
2026-04-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.